Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AUGA group Director's Dealing 2020

Apr 22, 2020

2259_rns_2020-04-22_7e8a2ad7-8421-4923-85c3-2ee252940f75.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Anesthesia and Intensive Care Unit

ARMANDAS ŠIMULIS

2020-04-21 15:37:04 GMT+3

Paekhts Paradas

Notification of transaction by person discharging managerial responsibilities

1. Details of the person discharging managerial responsibilities
a) Name Armandas Šimulis
2. Reason for the notification
a) Position/status Acting Head of R&D Department
b) Initial notification/ Amendment Initial notification
3. Details of the issuer
a) Name AUGA group, AB
b) LEI 48510000P2S3LHJPX414
4. Details of the transaction
a) Description of the financial instrument, type of instrument Identification code Execution of option agreement to obtain issuer’s shares in the future N/A
b) Nature of the transaction Execution of the share option agreement to obtain issuer’s shares in the future under the Programme for granting issuer’s shares to employees, management and supervisory board members of the issuer and its subsidiaries approved by the general shareholders’ meeting on 2018-04-30
c) Price and volume Price Volume
EUR 0 45 000 units
d) Aggregated information — Aggregated volume — Price Employee shall after 3 years be entitled to elect to get from the issuer up to 45 000 units of the issuer’s shares Shares shall be granted to the employee for free (i.e. for EUR 0)
e) Date of the transaction 2020-04-21
f) Place of the transaction Outside a trading venue

Note: This option agreement was executed under the Programme for granting issuer's shares to employees, management and supervisory board members of the issuer and its subsidiaries approved by the general shareholders' meeting on 2018-04-30

Armandas Šimulis, Acting Head of R&D Department

/name, surname, position, signature/